Trogenix, the Edinburgh pioneering biotech company, has completed a $95 million Series A funding round. The funding will enable the rapid advancement of its pipeline of innovative focussed cancer therapies …
The post Trogenix raises $95m Series A appeared first on Electronics Weekly .